ProfileGDS4718 / 205979_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 52% 41% 20% 79% 73% 39% 26% 58% 63% 67% 73% 46% 34% 25% 44% 89% 74% 41% 37% 29% 74% 68% 73% 79% 67% 29% 74% 18% 41% 36% 60% 29% 30% 54% 28% 41% 44% 69% 43% 19% 30% 20% 27% 27% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.6336452
GSM549102patient 115, normal, homogenized [OPG study]5.0743341
GSM549104patient 119, normal, homogenized [OPG study]4.1135320
GSM549108patient 138, normal, homogenized [OPG study]7.6832679
GSM549119patient 077, normal, homogenized [OPG study]7.0610373
GSM549133patient 032, cancer, homogenized [OPG study]4.9059839
GSM549139patient 042, cancer, homogenized [OPG study]4.3685926
GSM549099patient 107, normal, homogenized [OPG study]6.0040258
GSM549109patient 139, normal, homogenized [OPG study]6.3316763
GSM549110patient 046, normal, homogenized [OPG study]6.5796267
GSM549114patient 063, normal, homogenized [OPG study]7.1035573
GSM549122patient 082, normal, homogenized [OPG study]5.319446
GSM549134patient 033, cancer, homogenized [OPG study]4.7117534
GSM549136patient 036, cancer, homogenized [OPG study]4.2925625
GSM549140patient 044, cancer, homogenized [OPG study]5.1647244
GSM549111patient 047, normal, homogenized [OPG study]9.0661589
GSM549113patient 057, normal, homogenized [OPG study]7.331574
GSM549132patient 031, cancer, homogenized [OPG study]5.0001941
GSM549137patient 038, cancer, homogenized [OPG study]4.8225437
GSM549142patient 047, cancer, homogenized [OPG study]4.6038129
GSM549100patient 110, normal, homogenized [OPG study]7.2005574
GSM549107patient 135, normal, homogenized [OPG study]6.7041268
GSM549115patient 068, normal, homogenized [OPG study]7.1477573
GSM549116patient 072, normal, homogenized [OPG study]7.7377879
GSM549120patient 078, normal, homogenized [OPG study]6.5959167
GSM549131patient 030, cancer, homogenized [OPG study]4.4619429
GSM549118patient 074, normal, homogenized [OPG study]7.2329774
GSM549129patient 027, cancer, homogenized [OPG study]4.0997318
GSM549123patient 088, normal, homogenized [OPG study]5.0094741
GSM549124patient 006, cancer, homogenized [OPG study]4.8304536
GSM549126patient 015, cancer, homogenized [OPG study]6.1052160
GSM549128patient 025, cancer, homogenized [OPG study]4.4809829
GSM549103patient 117, normal, homogenized [OPG study]4.5967130
GSM549117patient 073, normal, homogenized [OPG study]5.7209254
GSM549138patient 041, cancer, homogenized [OPG study]4.4271728
GSM549141patient 045, cancer, homogenized [OPG study]4.9592241
GSM549130patient 028, cancer, homogenized [OPG study]5.2190344
GSM549101patient 111, normal, homogenized [OPG study]6.7984169
GSM549105patient 128, normal, homogenized [OPG study]5.1731443
GSM549106patient 134, normal, homogenized [OPG study]4.0536919
GSM549112patient 048, normal, homogenized [OPG study]4.5434630
GSM549125patient 011, cancer, homogenized [OPG study]4.1734120
GSM549127patient 024, cancer, homogenized [OPG study]4.4188427
GSM549135patient 035, cancer, homogenized [OPG study]4.3666227